Understanding the extent to which the general public justifies intimate partner violence (IPV) is necessarily to explain perpetration, victimization, and response to this behavior. This article provides a literature review of quantitative studies measuring IPV justification among the general population. Key word searching of two databases plus bibliographies, and the web yielded 23 studies that provided comparable measures of IPV justification. Results are summarized for the prevalence of IPV justification identified for each country including differences in justification based on the initiating event (e.g., burning food and infidelity), sociodemographic differences in justification and differences across countries. No study identified a zero prevalence of IPV justification and percentages varied considerably across and within countries. Females tended to report a higher rate of IPV justification than males and younger respondents tended to report a higher rate IPV justification than their older counterparts. Further research is needed to understand IPV justification within and across nations as well as to explore the impact this has on IPV prevalence and policy.
This article reports resultsof an ongoing studyof femicide in New York City. Using medical examiner records, femicides occurring between 1990 and 1999 were categorized according to whether an intimate partner perpetrated the homicide. Descriptive analyses results revealed that most femicide victims were young, Black, and killed in poor neighborhoods. Among cases with a known perpetrator, 40% were intimate partner femicides. Whereas the rate of nonintimate partner femicide decreased between 1990 and 1999, the rate of intimate partner femicide remained relatively stable. Multivariate analyses revealed that the strongest predictors of femicide by an intimate partner included having children under 18, living in a private residence, and being foreign born. Homicide followed by the suicide of the offender was also strongly associated with intimate partner femicide. Intimate partner femicide exhibits a unique epidemiology, and this knowledge should be used to plan and guide prevention activities.
BackgroundLittle research on Intimate Partner Violence (IPV) and social perceptions toward this behavior has been disseminated from Eastern Europe. This study explores the prevalence and risk factors of IPV and the justification of this behavior among women in the Republic of Georgia. It seeks to better understand how IPV and IPV justification relate and how social justification of IPV differs across socio-economic measures among this population of women.MethodsThis study utilizes a national sample of ever-married women from the Republic of Georgia (N = 4,302). We describe the factors that predict IPV justification among these women and the relationship between of the acceptability of IPV and victimization overall and across socio-demographic factors.ResultsWhile the overall lifetime prevalence of IPV in this sample was relatively low (4%), these women were two to four times more likely to justify IPV, Just under one-quarter of the sample agreed that IPV was justified in at least one scenario, namely when the wife was unfaithful, compared with women who had no experience being abused by a partner. Georgian women who were poor, from a rural community, had lower education, were not working and who experienced child abuse or IPV among their parents were more likely to justify this behavior.ConclusionsThese findings begin to fill a gap in our understanding of IPV experienced by women in Eastern Europe. In addition, these findings emphasize the need for researchers, practitioners and policy makers to contextualize IPV in terms of the justification of this behavior among the population being considered as this can play an important role in perpetration, victimization and response.
With the goal of understanding the true extent of intimate partner violence (IPV), researchers have put tremendous effort over the past 20 years developing, revising, and assessing IPV screening instruments. The enhancements made in IPV instrumentation reflect our improved understanding of the nature of IPV. Unfortunately, as is often the case with progress, we are presently at the stage where IPV researchers have an arsenal of multiple IPV screens that are, in some cases, slightly different, whereas in others, the differences are sizeable. This article explores the evolution and variation of a sample of IPV screens. To further progress in IPV research, we must make conscious decisions concerning the best tool for our individual research. Simultaneously, we must enhance our understanding of how these IPV screening instruments overlap so that comparisons of IPV prevalence or incidence across time and population are possible.
Acupuncture therapy offered in the group setting was effective in reducing pain severity, pain interference, and depression in patients with chronic neck, back, or shoulder pain or osteoarthritis. Benefit persisted through the 24-week measure despite no additional treatment. This finding has potentially important implications for improving access to effective acupuncture treatment for patients with limited financial resources.
Journal of Patient-Centered Research and Reviews ( JPCRR) is a peerreviewed scientific journal whose mission is to communicate clinical and bench research findings, with the goal of improving the quality of human health, the care of the individual patient, and the care of populations. Recommended CitationGinzburg R, Conway JJ, Waltermaurer E, Song W, Jellinek-Cohen SP. Using clinical decision support within the electronic health record to reduce incorrect prescribing for acute sinusitis.
The herpes zoster (shingles) vaccine is recommended for all adults aged ≥ 60 years without contraindications to prevent shingles and post-herpetic neuralgia. There are no published studies on zoster vaccination rates, barriers, or workflows in adults who have experienced homelessness. Due to barriers specific to this vaccine, including difficulty determining insurance coverage, high upfront costs, need for storage in a freezer, and under-prescription by physicians, uptake is lower compared to other recommended vaccines for older adults. To address these barriers, we developed a new approach of partnering our on-site primary care clinic in a transitional homeless shelter with a local pharmacy and offering vaccination on Shingles Immunization Days with a goal of matching or exceeding the national zoster immunization rate of 30.6%. Over a 3-year period, the live attenuated zoster vaccine was offered to 86% of eligible patients resulting in an immunization rate of 38.1%. This is higher than the estimated national rate but significantly lower than rates of tetanus (80.6%), pneumococcal (76.3%), and influenza (69.6%) vaccination in the same population, highlighting the unique obstacles to zoster immunization. Major reasons that patients were not immunized included lack of insurance coverage and patient refusal of all vaccines. Our findings demonstrate that homeless adults are interested in zoster vaccination and a model of on-site primary care in a shelter partnering with a pharmacy can successfully improve vaccine uptake in this population. Coverage of the new inactivated zoster vaccine under Medicare Part B could increase the national zoster immunization rate.
This retrospective study conducted in a real-world setting using electronic health record data demonstrates a shift in resource use by diabetic patients from the primary care clinician to other members of the care team. The findings suggest that PCMH implementation has the potential to alter processes of care and improve outcomes of care, especially among those with higher disease burden.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.